Merozoite Surface Protein 1 of Plasmodium vivax Induces a Protective Response against Plasmodium cynomolgi Challenge in Rhesus Monkeys
暂无分享,去创建一个
S. Puri | D. Lanar | S. Dutta | L. Ware | D. Kaushal | N. A. Kaushal | A. Narula | D. Upadhyaya
[1] D. Webster,et al. Safety, immunogenicity and efficacy of a pre-erythrocytic malaria candidate vaccine, ICC-1132 formulated in Seppic ISA 720. , 2005, Vaccine.
[2] J. Barnwell,et al. The Clinical-Grade 42-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium falciparum Strain FVO Expressed in Escherichia coli Protects Aotus nancymai against Challenge with Homologous Erythrocytic-Stage Parasites , 2005, Infection and Immunity.
[3] Virander S. Chauhan,et al. Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli , 2004, Infection and Immunity.
[4] D. Carucci,et al. Update on the clinical development of candidate malaria vaccines. , 2004, The American journal of tropical medicine and hygiene.
[5] A. Saul,et al. Biochemical and Immunological Characterization of Bacterially Expressed and Refolded Plasmodium falciparum 42-Kilodalton C-Terminal Merozoite Surface Protein 1 , 2003, Infection and Immunity.
[6] J. Haynes,et al. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine. , 2003, Molecular and biochemical parasitology.
[7] A. Kaneko,et al. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Gatton,et al. Nature and Specificity of the Required Protective Immune Response That Develops Postchallenge in Mice Vaccinated with the 19-Kilodalton Fragment of Plasmodium yoelii Merozoite Surface Protein 1 , 2002, Infection and Immunity.
[9] J. K. Moch,et al. Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the Plasmodium falciparum Apical Membrane Antigen 1 Expressed in Escherichia coli , 2002, Infection and Immunity.
[10] A. Holder,et al. Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region , 2002, Infection and Immunity.
[11] D. Kaushal,et al. DIAGNOSIS OF MALARIA BY DETECTION OF PLASMODIAL LACTATE DEHYDROGENASE WITH AN IMMUNODOT ENZYME ASSAY , 2002, Immunological investigations.
[12] C. Ockenhouse,et al. Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli , 2001, Infection and Immunity.
[13] A. Holder,et al. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. , 2001, Journal of molecular biology.
[14] M. Blackman,et al. Host cell invasion by malaria parasites. , 2000, Parasitology today.
[15] M. Blackman,et al. Immunogenicity and Efficacy in Aotus Monkeys of Four Recombinant Plasmodium falciparum Vaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1 , 2000, Infection and Immunity.
[16] Q. Cheng,et al. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. , 2000, Vaccine.
[17] A. Holder,et al. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies. , 1999, Molecular and biochemical parasitology.
[18] Paul H. Bessette,et al. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Bentley,et al. The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. , 1999, Molecular cell.
[20] D. Kaslow,et al. Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys. , 1999, The American journal of tropical medicine and hygiene.
[21] A. Holder,et al. Malaria vaccines. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Pronk,et al. High-Level Expression of Plasmodium vivax Apical Membrane Antigen 1 (AMA-1) in Pichia pastoris: Strong Immunogenicity in Macaca mulatta Immunized with P. vivax AMA-1 and Adjuvant SBAS2 , 1999, Infection and Immunity.
[23] D. Kaslow,et al. Partial Protection against Plasmodium vivaxBlood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer Adjuvant , 1999, Infection and Immunity.
[24] K. Mendis,et al. Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for HumanPlasmodium vivax Malaria , 1998, Infection and Immunity.
[25] K. Mendis,et al. Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response. , 1997, Molecular and biochemical parasitology.
[26] Virander S. Chauhan,et al. Cloning and sequence analysis of a gene encoding an erythrocyte binding protein from Plasmodium cynomolgi. , 1997, Molecular and biochemical parasitology.
[27] A. Holder,et al. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. , 1997, Vaccine.
[28] P. Barr,et al. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria , 1996, Infection and immunity.
[29] S. Longacre. The Plasmodium cynomolgi merozoite surface protein 1 C-terminal sequence and its homologies with other Plasmodium species. , 1995, Molecular and biochemical parasitology.
[30] Virander S. Chauhan,et al. Sequence analysis of apical membrane antigen 1 (AMA-1) of Plasmodium cynomolgi bastianelli. , 1995, Molecular and biochemical parasitology.
[31] W. Collins,et al. Immunologic characterization of Plasmodium vivax antigens using Plasmodium cynomolgi liver stage-primed immune sera. , 1994, The American journal of tropical medicine and hygiene.
[32] K. Mendis,et al. Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. , 1994, Molecular and biochemical parasitology.
[33] A. Holder,et al. Immunization against malaria with a recombinant protein , 1994, Parasite immunology.
[34] T. McCutchan,et al. Evolutionary relatedness of some primate models of Plasmodium. , 1993, Molecular biology and evolution.
[35] Mary R. Galinski,et al. A reticulocyte-binding protein complex of plasmodium vivax merozoites , 1992, Cell.
[36] P. Barr,et al. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. , 1992, Molecular and biochemical parasitology.
[37] A. Holder,et al. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. , 1991, Molecular and biochemical parasitology.
[38] Dutta Gp,et al. Infectivity studies on anopheles stephensi using Plasmodium cynomolgi B infection in rhesus monkeys. , 1989 .
[39] J. Barnwell,et al. Characterization of cross-reactive blood-stage antigens of the Plasmodium cynomolgi complex using anti-Plasmodium vivax monoclonal antibodies. , 1988, The Journal of parasitology.
[40] M. Galinski,et al. The circumsporozoite gene of the plasmodium cynomolgi complex , 1987, Cell.
[41] R. Sinden,et al. Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. , 1982, The American journal of tropical medicine and hygiene.
[42] L. Miller,et al. Caveola--vesicle complexes in the plasmalemma of erythrocytes infected by Plasmodium vivax and P cynomolgi. Unique structures related to Schüffner's dots. , 1975, The American journal of pathology.
[43] S. Wolff,et al. Immune response of man to inoculation with Plasmodium cynomolgi and challenge with P. vivax. , 1966, Lancet.
[44] F. Stohlman,et al. Malaria in man. Infection by Plasmodium vivax and the B strain of Plasmodium cynomolgi. , 1963, JAMA.
[45] F. Stohlman,et al. Clinical and physiological responses in sporozoite-induced B strain Plasmodium cynomolgi and Plasmodium vivax infections in normal volunteers. , 1962, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[46] A Voller,et al. Enzyme immunoassays in diagnostic medicine. Theory and practice. , 1976, Bulletin of the World Health Organization.
[47] W. J. Langford. Statistical Methods , 1959, Nature.